Evaluation of RTVue XR With SSADA

Optovue

Status: Completed

Conditions: Retina Vascular Pathology

Study type: Observational

Funder types: Industry

Identifiers

NCT02535520

200-50547

Details and patient eligibility

About

Optovue has implemented a motion contrast imaging software in RTVue XR, a split spectrum amplitude decorrelation algorithm (SSADA), for non-invasive imaging of ocular vasculature. Consented subjects will undergo a series of images of the back of the eye using an Optical Coherence Tomograpy (OCT) device, RTVue XR, in addition to the conventional images as part of clinical routine. SSADA images will be compared with conventional methods.

Enrollment: 155 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age >18
• Able and willing to complete exams
• Patients in retina clinic that need angiography

Exclusion criteria

• Unable to complete the required examinations and visits
• Large amount of subretinal hemorrhage
• Media opacity leading to poor quality images
• Extreme refractive error leading to poor quality images
• Pathologies in the anterior segment leading to poor quality images